Chemours (CC) Income from Continuing Operations (2014 - 2026)

Chemours has reported Income from Continuing Operations for 13 years, with the latest figure at -$274.0 million in Q2 2026.

• On a quarterly basis, Income from Continuing Operations rose 27.7% year-over-year to -$274.0 million in Q2 2026; TTM through Jun 2026 was -$305.0 million, a 28.57% increase from a year earlier, with the FY2025 full-year figure at -$562.0 million, down 309.7% from the prior year.
• Income from Continuing Operations was -$274.0 million for Q2 2026 at Chemours, down from -$29.0 million in the prior quarter.
• The five-year high for Income from Continuing Operations was $240.0 million in Q3 2022, with the low at -$379.0 million in Q2 2025.
• Average Income from Continuing Operations over 5 years is -$15.1 million, with a median of -$8.0 million recorded in 2024.
• The largest YoY upside for Income from Continuing Operations was 243.75% in 2025 against a maximum downside of 731.67% in 2025.
• Over 5 years, Income from Continuing Operations stood at -$97.0 million in 2022, then surged by 87.63% to -$12.0 million in 2023, then increased by 8.33% to -$11.0 million in 2024, then slumped by 336.36% to -$48.0 million in 2025, then plunged by 470.83% to -$274.0 million in 2026.
• The last three Income from Continuing Operations figures came in at -$274.0 million (Q2 2026), -$29.0 million (Q1 2026), and -$48.0 million (Q4 2025), per Business Quant data.